A frequent somatic mutation in CD274 3′‐UTR leads to protein over‐expression in gastric cancer by disrupting miR‐570 binding

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Mutation

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/humu.22014PMID 22190470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis.

  2011cited by this paper
• Quantitative determination of allele frequency in pooled DNA by using sequencing method.

  2011cited by this paper
• Genetic variation in microRNA networks: the implications for cancer research

  2010cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes12

  2009cited by this paper
• Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.

  2009cited by this paper
• Over- and under-expressed microRNAs in human colorectal cancer.

  2009cited by this paper
• Inhibitory B7-family molecules in the tumour microenvironment

  2008cited by this paper
• Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

  2007cited by this paper
• Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns.

  2007cited by this paper
• Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

  2007cited by this paper
• Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.

  2006cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

  1999influential reference

• Amniotic membrane placement without endotamponade for optic nerve coloboma with extensive serous retinal detachment in papillorenal syndrome: A case report

  2025cites this paper
• circRNA_0005927 inhibits gastric cancer metastasis by downregulating the miR-570-3p/FOXO3 axis.

  2025cites this paper
• Biomarker-oriented chemo-immunotherapy for advanced gastric cancer

  2024cites this paper
• Rapid Sex Identification in Spotted Knifejaw (Oplegnathus punctatus) Using tmem88 Gene Structural Variation Markers

  2024cites this paper
• Programmed Death Ligand -1 Expression and Gastric Mucosal Nodularity as an Indicator of Helicobacter Pylori Associated Gastritis and Gastric Carcinoma

  2024cites this paper
• Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci

  2024cites this paper
• Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer

  2023cites this paper
• Polymorphisms of the PD‐L1 gene 3′‐untranslated region are associated with the expression of PD‐L1 in non‐small cell lung cancer

  2023cites this paper
• PD-L1: expression regulation

  2023cites this paper
• Inhibitory Effect of miRNA-145 on PD-L1 Expression in Breast Cancer Cell Line

  2022cites this paper
• PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer

  2022cites this paper
• Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.

  2022cites this paper
• The mechanisms on evasion of anti-tumor immune responses in gastric cancer

  2022cites this paper
• Epigenetic modifications: Critical participants of the PD-L1 regulatory mechanism in solid tumors (Review)

  2022influential citation
• Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells

  2022cites this paper
• Association of the rs4143815 polymorphism of PDL1 gene with HTLV‐1 infection and proviral load in asymptomatic blood donors in northeast Iran

  2022cites this paper
• MicroRNAs and their role in immunogenetic-dysregulation

  2022cites this paper
• MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors

  2021cites this paper
• ceRNAs in Cancer: Mechanism and Functions in a Comprehensive Regulatory Network

  2021cites this paper
• The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment

  2021cites this paper
• A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.

  2021cites this paper
• Computational cancer genomics

  2021cites this paper
• miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.

  2021cites this paper
• PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors

  2021cites this paper
• miRNAs as novel immunoregulators in cancer.

  2021cites this paper
• Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.

  2021cites this paper
• How metformin affects various malignancies by means of microRNAs: a brief review

  2021cites this paper
• A snapshot of the PD-1/PD-L1 pathway

  2021cites this paper
• Epstein–Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas

  2020cites this paper
• UBE2C mRNA expression controlled by miR-300 and HuR determines its oncogenic role in gastric cancer.

  2020cites this paper
• Defining the clinical genomic landscape for real-world precision oncology

  2020cites this paper
• The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment

  2020cites this paper
• Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors

  2020cites this paper
• The role of genetic polymorphism within PD-L1 gene in cancer. Review.

  2020cites this paper
• Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer

  2020cites this paper
• Current status of immune checkpoint inhibitors for gastric cancer

  2020cites this paper
• RNA-biology ruling cancer progression? Focus on 3′UTRs and splicing

  2020cites this paper
• Retracted: Protective effect of hsa‐miR‐570‐3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway

  2020cites this paper
• Regulations on Messenger RNA: Wires and Nodes.

  2020cites this paper
• Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin-Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform.

  2019cites this paper
• Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival

  2019cites this paper
• rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy

  2019cites this paper
• Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

  2019cites this paper
• CD44 Gene rs8193 C Allele Is Significantly Enriched in Gastric Cancer Patients

  2019cites this paper
• Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade

  2019cites this paper
• IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

  2019cites this paper
• Current concepts of non-coding RNA regulation of immune checkpoints in cancer.

  2019cites this paper
• Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.

  2019cites this paper
• Regulation of PD-1/PD-L1 Pathway in Cancer by Noncoding RNAs

  2019cites this paper
• Basis of PD1/PD-L1 Therapies

  2019cites this paper
• Key questions about the checkpoint blockade-are microRNAs an answer?

  2018cites this paper
• miR-570 Inhibits Proliferation, Angiogenesis, and Immune Escape of Hepatocellular Carcinoma

  2018cites this paper
• Regulation of the immune checkpoint PD-L1 by microRNAs

  2018cites this paper
• Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy

  2018cites this paper
• Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations

  2018cites this paper
• New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression

  2018cites this paper
• Epigenetic regulators of programmed death‐ligand 1 expression in human cancers

  2018cites this paper
• Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer

  2017cites this paper
• Altered TERT promoter and other genomic regulatory elements: occurrence and impact

  2017cites this paper
• Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.

  2017cites this paper
• Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape

  2017cites this paper
• Programmed death-1 ligand-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers

  2017cites this paper
• Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells

  2017cites this paper
• A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer

  2017influential citation
• Cancer Hallmarks and MicroRNAs: The Therapeutic Connection

  2017cites this paper
• A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer

  2017cites this paper
• Targeting the PD-1 pathway: a new hope for gastrointestinal cancers

  2017cites this paper
• Tumor Suppressor microRNAs Contribute to the Regulation of PD‐L1 Expression in Malignant Pleural Mesothelioma

  2017cites this paper
• Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression

  2017cites this paper
• Tumor cell-associated immune checkpoint molecules - Drivers of malignancy and stemness.

  2017cites this paper
• Prioritisation of non-coding somatic mutations in cancer

  2017cites this paper
• Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival

  2017cites this paper
• Noncoding RNAs and immune checkpoints—clinical implications as cancer therapeutics

  2017cites this paper
• Somatic Variations in Cervical Cancers in Indian Patients

  2016cites this paper
• Beyond the exome: the role of non-coding somatic mutations in cancer.

  2016cites this paper
• The PD-1:PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives.

  2016influential citation
• TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis

  2016cites this paper
• The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations

  2016cites this paper
• Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer

  2015cites this paper
• VHL and HIF in Clear Cell Renal Cell Carcinoma: Molecular Abnormalities and Potential Clinical Applications

  2015cites this paper
• MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma

  2015cites this paper
• MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.

  2015cites this paper
• Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

  2015cites this paper
• Causes of genome instability: the effect of low dose chemical exposures in modern society.

  2015cites this paper
• The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy

  2015cites this paper
• Identify Critical Genes in Development with Consistent H3K4me2 Patterns across Multiple Tissues

  2015cites this paper
• Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma

  2015cites this paper
• MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells.

  2014cites this paper
• Original Article MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells

  2014cites this paper
• Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma

  2014cites this paper
• MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer.

  2014cites this paper
• A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma

  2013cites this paper
• An MLPA‐Based Strategy for Discrete CNV Genotyping: CNV‐miRNAs as an Example

  2013cites this paper
• Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk

  2012cites this paper
• MicroRNAs as promising biomarkers for gastric cancer

  2012cites this paper